Dr. Lana Al-Rashdan, MD

Dr. Al-Rashdan practices at OHSU Hospital in Portland, Oregon, part of State of Oregon.

Dr. Al-Rashdan's NPI, 1497334643, was assigned on April 5, 2021. Dr. Al-Rashdan holds Oregon license MD221949.

Dr. Al-Rashdan's primary practice is OHSU Hospital, at 3181 SW Sam Jackson Park Road, Portland, OR 97239 in Multnomah County. The practice phone is (503) 494-9000.

Dr. Al-Rashdan's primary practice is OHSU Hospital in Portland, Oregon, part of State of Oregon. The medical group on file is Oregon Health & Science University (OHSU). Dmand AI also links Dr. Al-Rashdan to 1 more clinical lab, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al-Rashdan practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Al-Rashdan's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Al-Rashdan is licensed in Oregon.

CMS data shows 15 Medicare services from Dr. Al-Rashdan across 1 procedure code in 2024, for 22 Medicare patients. Medicare paid $2,054 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 22 Medicare patients who saw Dr. Al-Rashdan in 2024. 75% of them have high blood pressure, and 68% have high cholesterol. Their average risk score is 2.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Al-Rashdan's median patient age at 46, with 100% women.

In 2024, Dr. Al-Rashdan wrote 359 Medicare Part D claims for 62 patients. 93% of them were for generic drugs. CMS names the drug for 152 of them, across 10 drugs with 11 or more claims each, at $3,289 in total drug cost. In 2023, CMS named 64 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Al-Rashdan for performance year 2024, reported through an alternative payment model (APM).

Dmand AI links 6 papers to Dr. Al-Rashdan, published from 2021 to 2022. 2021 was the busiest year, with 4. The most frequent topics are Atrial Fibrillation, Cardiomyopathies and Prealbumin. Dr. Al-Rashdan has published most often in Int J Cardiol. Dr. Al-Rashdan's most frequent co-authors are Zack Joseph Dale, MD, Babak Nazer, MD and Stephen Barri Heitner, MD.

CMS Open Payments shows 1 general payment to Dr. Al-Rashdan from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Cleerly, Inc. paid the most, $23.